Retractable Technologies's ROE % for the quarter that ended in Mar. 2026 was -23.40%. Retractable Technologies's PB Ratio for the quarter that ended in Mar. 2026 was 0.28.
Retractable Technologies's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -83.57%.
Retractable Technologies ROE % Adjusted to Book Value Related Terms
Retractable Technologies ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Retractable Technologies's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Retractable Technologies ROE % Adjusted to Book Value Chart
RVP vs ZJYL, FEMY, UEEC: ROE % Adjusted to Book Value Comparison
For the Medical Instruments & Supplies subindustry, Retractable Technologies's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Retractable Technologies ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Retractable Technologies's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Retractable Technologies's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of -83.57% mean?
Retractable Technologies (RVP) has a ROE % Adjusted to Book Value of -83.57% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Retractable Technologies and its competitors.
Is Retractable Technologies' ROE % Adjusted to Book Value too high?
Retractable Technologies' current ROE % Adjusted to Book Value is -83.57%. Overall, Retractable Technologies has a GF Score™ of 35/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Retractable Technologies' ROE % Adjusted to Book Value compare to ZJYL and FEMY?
Retractable Technologies' ROE % Adjusted to Book Value of -83.57% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Retractable Technologies and its competitors. Retractable Technologies's current ROE % Adjusted to Book Value is -83.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Retractable Technologies stock overvalued right now?
Based on GuruFocus' analysis, Retractable Technologies (RVP) is currently considered Fairly Valued. The stock's GF Value™ is $0.77, compared to a current price of $0.70 — trading 9.4% below its estimated fair value. The current ROE % Adjusted to Book Value is -83.57%. Retractable Technologies' overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Retractable Technologies (RVP), the current ROE % Adjusted to Book Value is -83.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Retractable Technologies (RVP) Overvalued in 2026?
Based on GuruFocus' analysis, Retractable Technologies stock appears to be undervalued.
The current stock price of $0.70 is trading 9.4% below its estimated GF Value™ of $0.77.
GuruFocus considers Retractable Technologies to be Fairly Valued.
Key valuation signals for RVP:
ROE % Adjusted to Book Value: -83.57%
GF Value™: $0.77 vs. price of $0.70 (9.4% below fair value)
No single metric tells the full story. See the RVP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.
35GF Score
Get the complete analysis for RVP
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RVP has been successfully added to your 
